Mirum Pharmaceuticals (MIRM) Competitors $74.42 -1.77 (-2.32%) Closing price 04:00 PM EasternExtended Trading$74.42 +0.00 (+0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM vs. ASND, RDY, VTRS, ROIV, BBIO, MRNA, QGEN, ELAN, VRNA, and RVMDShould you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), BridgeBio Pharma (BBIO), Moderna (MRNA), QIAGEN (QGEN), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. Mirum Pharmaceuticals vs. Its Competitors Ascendis Pharma A/S Dr. Reddy's Laboratories Viatris Roivant Sciences BridgeBio Pharma Moderna QIAGEN Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Ascendis Pharma A/S (NASDAQ:ASND) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk. Which has more risk & volatility, ASND or MIRM? Ascendis Pharma A/S has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Is ASND or MIRM more profitable? Mirum Pharmaceuticals has a net margin of -13.65% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ascendis Pharma A/S-54.94% N/A -24.31% Mirum Pharmaceuticals -13.65%-24.76%-8.50% Which has stronger earnings and valuation, ASND or MIRM? Mirum Pharmaceuticals has higher revenue and earnings than Ascendis Pharma A/S. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than Ascendis Pharma A/S, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscendis Pharma A/S$393.54M32.45-$409.12M-$5.16-40.12Mirum Pharmaceuticals$429.16M8.71-$87.94M-$1.21-61.50 Does the media refer more to ASND or MIRM? In the previous week, Ascendis Pharma A/S had 1 more articles in the media than Mirum Pharmaceuticals. MarketBeat recorded 14 mentions for Ascendis Pharma A/S and 13 mentions for Mirum Pharmaceuticals. Mirum Pharmaceuticals' average media sentiment score of 0.82 beat Ascendis Pharma A/S's score of 0.61 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascendis Pharma A/S 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Mirum Pharmaceuticals 4 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ASND or MIRM? Ascendis Pharma A/S currently has a consensus target price of $248.29, indicating a potential upside of 19.93%. Mirum Pharmaceuticals has a consensus target price of $76.91, indicating a potential upside of 3.34%. Given Ascendis Pharma A/S's higher possible upside, equities analysts clearly believe Ascendis Pharma A/S is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascendis Pharma A/S 1 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.88Mirum Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryMirum Pharmaceuticals beats Ascendis Pharma A/S on 9 of the 15 factors compared between the two stocks. Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRM vs. The Competition Export to ExcelMetricMirum PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.74B$3.38B$6.13B$10.46BDividend YieldN/A2.30%5.73%4.78%P/E Ratio-61.5022.9185.0627.23Price / Sales8.71439.69573.27177.38Price / CashN/A46.1137.3961.86Price / Book15.8310.4812.386.64Net Income-$87.94M-$52.47M$3.32B$276.79M7 Day Performance0.81%-1.06%-0.27%-1.54%1 Month Performance0.85%14.40%9.52%5.44%1 Year Performance87.08%13.86%71.62%36.30% Mirum Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRMMirum Pharmaceuticals3.2175 of 5 stars$74.42-2.3%$76.91+3.3%+91.9%$3.74B$429.16M-61.50140Analyst ForecastAnalyst RevisionASNDAscendis Pharma A/S3.105 of 5 stars$208.43-0.5%$248.29+19.1%+62.7%$12.93B$393.54M-40.391,017News CoverageAnalyst ForecastAnalyst RevisionGap UpRDYDr. Reddy's Laboratories2.828 of 5 stars$14.36+0.1%$16.95+18.1%-11.0%$11.97B$3.81B21.7527,811News CoverageVTRSViatris2.2316 of 5 stars$9.86+1.2%$10.40+5.5%-15.7%$11.36B$14.74B-3.4032,000News CoverageAnalyst ForecastROIVRoivant Sciences3.0242 of 5 stars$16.21+1.1%$19.94+23.0%+43.0%$10.95B$29.05M-23.16860Insider TradeBBIOBridgeBio Pharma4.3037 of 5 stars$55.96+0.8%$63.94+14.3%+123.1%$10.61B$221.90M-13.68400Analyst RevisionMRNAModerna4.2566 of 5 stars$26.74-0.3%$41.81+56.4%-51.6%$10.48B$3.24B-3.555,800QGENQIAGEN4.2586 of 5 stars$47.30+1.0%$49.40+4.4%+11.5%$10.41B$1.98B27.955,765ELANElanco Animal Health2.7807 of 5 stars$20.04+1.4%$19.14-4.5%+47.1%$9.82B$4.44B23.309,000Analyst RevisionVRNAVerona Pharma PLC American Depositary Share1.4602 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.2591 of 5 stars$48.75+1.1%$74.64+53.1%+1.2%$9.02B$11.58M-10.83250Analyst ForecastInsider Trade Related Companies and Tools Related Companies Ascendis Pharma A/S Competitors Dr. Reddy's Laboratories Competitors Viatris Competitors Roivant Sciences Competitors BridgeBio Pharma Competitors Moderna Competitors QIAGEN Competitors Elanco Animal Health Competitors Verona Pharma PLC American Depositary Share Competitors Revolution Medicines Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRM) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
